ERBB2 and breast carcinoma: The mitogen-activated protein kinase (MAPK) signaling-mediated overexpression of miR-21 induces tumorigenesis- and metastasis-associated phenotypes, including cell migration and invasion in lung cancer [16], EGF-induced pancreatic cancer [17], and Her2/neu-overexpressing breast cancer [18].